Hormone Receptor Status Does Not Affect Prognosis in Metaplastic Breast Cancer: A Population-Based Analysis with Comparison to Infiltrating Ductal and Lobular Carcinomas
- 17 May 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 21 (11), 3497-3503
- https://doi.org/10.1245/s10434-014-3782-7
Abstract
Background Metaplastic breast cancer is a rare histologic variant among breast cancers. We sought to investigate the impact of hormone receptor status in metaplastic breast cancer and compare outcomes...This publication has 11 references indexed in Scilit:
- The prognostic significance of metaplastic carcinoma of the breast (MCB) – A case controlled comparison study with infiltrating ductal carcinomaThe Breast, 2013
- Metaplastic breast cancer: clinicopathological features and its prognosisJournal of Clinical Pathology, 2012
- The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patientsBreast Cancer Research and Treatment, 2011
- Diagnostic utility of snail in metaplastic breast carcinomaDiagnostic Pathology, 2010
- Metaplastic Breast Cancer: To Radiate or Not to Radiate?Annals of Surgical Oncology, 2010
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancerBreast Cancer Research and Treatment, 2010
- Characteristics and Treatment of Metaplastic Breast Cancer: Analysis of 892 Cases from the National Cancer Data BaseAnnals of Surgical Oncology, 2006
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006
- Metaplastic breast cancer: clinical significanceThe American Journal of Surgery, 2006
- Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expressionBreast Cancer Research and Treatment, 2005